[Form 4] RXO, Inc. Insider Trading Activity
RXO, Inc. (RXO) director reported an open-market purchase of company stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
RXO, Inc. (RXO) director reported an open-market purchase of company stock. On 11/20/2025, the reporting person bought 8,317 shares of RXO common stock in a transaction coded "P" (purchase), at a weighted average price of $10.61 per share, within a price range of $10.45 to $10.75.
Following this transaction, the director beneficially owns 275,416 shares of RXO common stock directly. The filing notes that detailed trade data by price level is available upon request.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock | 8,317 | $10.61 | $88K |
Footnotes (1)
- F1. The purchase price ranged from $10.45 to $10.75, with a weighted average purchase price of $10.61. Upon request, the Reporting Person hereby undertakes to provide to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did RXO (RXO) report in this Form 4?
The Form 4 reports that a director of RXO, Inc. purchased 8,317 shares of RXO common stock on 11/20/2025 in an open-market transaction.
What does transaction code "P" mean in the RXO Form 4?
Transaction code "P" on Form 4 indicates an open-market or private purchase of non-derivative securities, in this case RXO common stock.
Did this RXO Form 4 include any derivative securities activity?
No derivative securities transactions are listed; Table II shows column headings but no derivative entries for this reporting person.
Who signed the RXO Form 4 and in what capacity?
The Form 4 was signed by /s/ Jeffrey D. Firestone as Attorney-in-Fact for the reporting person on 11/24/2025.
AI-generated analysis. How Rhea-AI works. Not financial advice.